RT Journal Article
SR Electronic
T1 The Prevalence of RT-PCR Positivity of SARS-CoV-2 on 10,000 Patients from Three Cities Located on the Eastern of Turkey
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.25.20138131
DO 10.1101/2020.06.25.20138131
A1 Karamese Murat
A1 Ozgur Didem
A1 Tarhan Ceyda
A1 Dik Altintas Susamber
A1 Caliskan Okan
A1 Tuna Aysegul
A1 Kazci Saliha
A1 Karadavut Mursel
A1 Gumus Abdullah
A1 Apaydin Gozde
A1 Mumcu Necati
A1 Coruh Onur
A1 Tutuncu Emin Ediz
YR 2020
UL http://medrxiv.org/content/early/2020/06/26/2020.06.25.20138131.abstract
AB COVID-19, is caused by SARS-CoV-2, has been started on December/2019 in Wuhan/China and spread all over the world. We analyzed RT-PCR results of 10,000 cases from April-2 to May-30, 2020 in three neighbor cities located on the Eastern of Turkey. The final study population was 7853 cases after excluded screening tests. RT-PCR were performed to detect the SARS-CoV-2-specific RdRp (RNA-dependent-RNA-polymerase) gene fragment. The number of total positive samples out of 7853 were 487; however, the number of non-repeating positive patient was 373 (4.8%). The cough and fever were the most common symptoms in positive cases. The epidemiologic studies should be performed about the prevalence of SARS-CoV-2 infection to better understand the effect of the virus all over the world.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by both the Republic of Turkey Ministry of Health COVID19 Scientific Research Evaluation Commission (Approval date: 02.05.2020; number: 2020-05-03T18_02_30) and the Local Ethics Committee of Kafkas University Faculty of Medicine (Approval date: 06.05.2020 number: 80576354-050-99/129).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe availability of all data referred to in the manuscript